299. 嚢胞性線維症 Cystic fibrosis Clinical trials / Disease details

臨床試験数 : 1,695 / 薬物数 : 1,527 - (DrugBank : 268) / 標的遺伝子数 : 111 - 標的パスウェイ数 : 174

6 trials found

diseases per page:

Showing 1 to 6 of 6 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	EUCTR2006-003275-12-NO (EUCTR)	03/06/2009	27/03/2009	Scandinavian Cystic Fibrosis Azithromycin StudySupplementary oral azithromycin in treatment of inter ...	Scandinavian Cystic Fibrosis Azithromycin StudySupplementary oral azithromycin in treatment of inter ...	Cystic fibrosis with intermittent colonization of the airways with pseudomonas aeruginosa. MedDRA ve ...	Trade Name: Zitromax Product Name: Zitromax Product Code: Zitromax INN or Proposed INN: AZITHROMYCIN Tra ...	Copenhagen CF-centre	NULL	NA			Female: yes Male: yes	250	Phase 4	Denmark;Norway;Sweden
2	NCT00411736 (ClinicalTrials.gov)	May 2008	14/12/2006	Scandinavian Cystic Fibrosis Azithromycin Study	Supplementary Oral Azithromycin in Treatment of Intermittent Pseudomonas Aeruginosa Colonization in ...	Cystic Fibrosis	Drug: Study medication, azithromycin or placebo;Drug: Azithromycin or placebo tablets	Rigshospitalet, Denmark	Cystic Fibrosis Foundation Therapeutics	Completed	1 Year	N/A	Both	45	Phase 4	Denmark;Norway;Sweden
3	EUCTR2006-003275-12-DK (EUCTR)	23/05/2007	17/04/2007	Scandinavian Cystic Fibrosis Azithromycin StudySupplementary oral azithromycin in treatment of inter ...	Scandinavian Cystic Fibrosis Azithromycin StudySupplementary oral azithromycin in treatment of inter ...	Cystic fibrosis with intermittent colonization of the airways with pseudomonas aeruginosa. MedDRA ve ...	Trade Name: Zitromax Product Name: zitromax Product Code: zitromax INN or Proposed INN: AZITHROMYCIN Tra ...	Copenhagen CF-centre	NULL	Not Recruiting			Female: yes Male: yes	250	Phase 4	Denmark
4	NCT00097773 (ClinicalTrials.gov)	September 2004	30/11/2004	Comparison of Two Treatment Regimens to Reduce PA Infection in Children With Cystic Fibrosis	Effectiveness and Safety of Intermittent Antimicrobial Therapy for the Treatment of New Onset Pseudo ...	Cystic Fibrosis;Pulmonary Disease, Chronic Obstructive	Drug: Tobramycin solution for inhalation (TOBI);Drug: Oral placebo;Drug: Oral ciprofloxacin	Seattle Children's Hospital	National Heart, Lung, and Blood Institute (NHLBI);Cystic Fibrosis Foundation Therapeutics;CF Therape ...	Completed	1 Year	12 Years	All	304	Phase 2	United States
5	NCT01400750 (ClinicalTrials.gov)	August 2001	18/7/2011	Comparison of 2 Treatment Regimens for Eradication of P Aeruginosa Infection in Children With Cystic ...	Prospective Randomized Trial Comparing Oral Ciproxin Plus Inhaled Colistin With Tobramycin for Inhal ...	Cystic Fibrosis	Drug: oral ciprofloxacin plus inhaled colistin;Drug: TOBI	Universitaire Ziekenhuizen Leuven	NULL	Completed	N/A	18 Years	Both	61	Phase 4	Belgium
6	EUCTR2006-003275-12-SE (EUCTR)		07/07/2009	Scandinavian Cystic Fibrosis Azithromycin StudySupplementary oral azithromycin in treatment of inter ...	Scandinavian Cystic Fibrosis Azithromycin StudySupplementary oral azithromycin in treatment of inter ...	Cystic fibrosis with intermittent colonization of the airways with pseudomonas aeruginosa. MedDRA ve ...	Trade Name: Azithromycin Product Name: azithromycin Product Code: azithromycin INN or Proposed INN: AZI ...	Copenhagen CF-centre	NULL	NA			Female: yes Male: yes	250	Phase 4	Denmark;Norway;Sweden

First Previous1Next Last